tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:B9A Stock Latest News

Is B9A a Buy, Before Earnings?
Pre-EarningsIs B9A a Buy, Before Earnings?
7h ago
BioArctic Sets February 18 Release and Investor Call for Q4 2025 Report
PremiumCompany Announcements
BioArctic Sets February 18 Release and Investor Call for Q4 2025 Report
5d ago
BioArctic’s Partner Eisai Wins Priority Review in China for At-Home Leqembi Alzheimer’s Injection
PremiumCompany Announcements
BioArctic’s Partner Eisai Wins Priority Review in China for At-Home Leqembi Alzheimer’s Injection
7d ago
BioArctic Royalty Income Climbs on Rising Global Sales of Alzheimer’s Drug Leqembi
PremiumCompany Announcements
BioArctic Royalty Income Climbs on Rising Global Sales of Alzheimer’s Drug Leqembi
10d ago
Eisai Seeks EU Approval for Monthly Leqembi Maintenance Dosing, Enhancing BioArctic’s Alzheimer’s Franchise
PremiumCompany Announcements
Eisai Seeks EU Approval for Monthly Leqembi Maintenance Dosing, Enhancing BioArctic’s Alzheimer’s Franchise
21d ago
BioArctic and Eisai Win FDA Priority Review for At‑Home Leqembi Autoinjector Start Dosing
PremiumCompany AnnouncementsBioArctic and Eisai Win FDA Priority Review for At‑Home Leqembi Autoinjector Start Dosing
22d ago
BioArctic Partner Eisai Wins China Review of At‑Home Leqembi Injection for Early Alzheimer’s
Premium
Company Announcements
BioArctic Partner Eisai Wins China Review of At‑Home Leqembi Injection for Early Alzheimer’s
1M ago
BioArctic’s Leqembi Gains Inclusion in China’s Innovative Drug List
Premium
Company Announcements
BioArctic’s Leqembi Gains Inclusion in China’s Innovative Drug List
2M ago
BioArctic’s Lecanemab Shows Promise in Delaying Alzheimer’s Progression
PremiumCompany Announcements
BioArctic’s Lecanemab Shows Promise in Delaying Alzheimer’s Progression
2M ago
BioArctic AB Expands Share Count Through Stock Option Program
PremiumCompany Announcements
BioArctic AB Expands Share Count Through Stock Option Program
3M ago
BioArctic and Eisai Submit Subcutaneous Leqembi Application in Japan
PremiumCompany Announcements
BioArctic and Eisai Submit Subcutaneous Leqembi Application in Japan
3M ago
Eisai Completes FDA Submission for Home-Use Alzheimer’s Treatment
PremiumCompany Announcements
Eisai Completes FDA Submission for Home-Use Alzheimer’s Treatment
3M ago
BioArctic’s Lecanemab Data to be Unveiled at CTAD Conference
PremiumCompany AnnouncementsBioArctic’s Lecanemab Data to be Unveiled at CTAD Conference
3M ago
BioArctic’s Alzheimer’s Treatment Leqembi Gains UK Approval for Maintenance Dosing
Premium
Company Announcements
BioArctic’s Alzheimer’s Treatment Leqembi Gains UK Approval for Maintenance Dosing
3M ago
BioArctic Expands Alzheimer’s Treatment Reach Amid Financial Losses
Premium
Company Announcements
BioArctic Expands Alzheimer’s Treatment Reach Amid Financial Losses
3M ago
B9A Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
B9A Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
BioArctic AB to Present Q3 2025 Financial Results
PremiumCompany Announcements
BioArctic AB to Present Q3 2025 Financial Results
3M ago
BioArctic Reports Surge in Leqembi® Royalties Amid Strong Sales
PremiumCompany Announcements
BioArctic Reports Surge in Leqembi® Royalties Amid Strong Sales
4M ago
Health Canada Approves Leqembi for Early Alzheimer’s Treatment
PremiumCompany Announcements
Health Canada Approves Leqembi for Early Alzheimer’s Treatment
4M ago
BioArctic AB Announces Formation of Nomination Committee for 2026 AGM
PremiumCompany AnnouncementsBioArctic AB Announces Formation of Nomination Committee for 2026 AGM
4M ago
BioArctic Launches Leqembi Treatment for Alzheimer’s in the Nordics
Premium
Company Announcements
BioArctic Launches Leqembi Treatment for Alzheimer’s in the Nordics
4M ago
BioArctic’s Alzheimer’s Treatment Recognized as Top Innovation by TIME
Premium
Company Announcements
BioArctic’s Alzheimer’s Treatment Recognized as Top Innovation by TIME
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >